BIBLIOGRAPHIE
1. ABDULKARIM SHEIBAN, AHMED SALEM, GARBA AL
Yemen nephrology-revisited
Sand J Kidney Dis Transplant 1998, 9(10)-36-39
2. ABU FARSAK NA, ROWELLY E, RABABAA M.
Evaluation of upper gastrointestinal tract in uremic patients
undergoing haemodialysis Nephrol Dial Transplant 1996; 11; 847-8-50
3. AFFIFY A
Annual report of the Egyptian society of nephrology registry:
1999. SJK Dial Transpl; 2000, 16:244-5
4. AGENCE NATIONALE POUR LE DEVELOPPEMENT DE
L'EVALUATION MEDICALE Indication de l'épuration
extrarénale dans l'IRC terminale. Recommandations pour la pratique
clinique. Paris ANDEM; 1996
Nephrol Dial Transpl: 19: 2537.
5. AL KHADER AA
Impact of diabetes in renal diseases in Saudi Arabia. Nephrol
Dial Transplant 2001, 16(11):2132-5
6. AL ROHANI M
Renal failure in Yemen
Transplant Proc 2004; 36:1777-9
7. AL WAKEEL JS, MITWALLI AH, TARIF N ET AL
Spectrum and outcome of primary glomerulonephritis S J Kidney Dial
Transplant 2004, 15:440-6
8. ALEXANDER, SEGHAL AR
Barriers to cadaveric renal transplantation among blacks women
and the poor Jama 1998, 280 :1148-52
9. ALFATAH FZ RAMIAS
Hepatitis C virus in Saudi Arabia: a review Ann Saudi Med 1997,
17:77-82
10. AMENABAR JJ, GARCIA LOPEZ F, ROBLES NR, SARACHO R ET
AL.
1997 Spanish nephrology association report on dialysis and
transplantation
Nephrol Dial. Transplant : 14 : 2845
11. AGENCE NATIONALE D'ACCREDITATION ET D'EVALUATION DE
LA SANTE (ANAES). Diagnostic de l'IRC chez l'adulte
Septembre 2002
Bulletin hebdomadaire ISBN 2-91
12. ANONYMES EXCEPTS FROM THE USRDS 1999 Annual
report AMJ kidney disease 1999; 34, SI-S176
13. ANONYMOUS WORLDWIDE REGISTRY INFORMATIONS
Compares the use dialysis population with several other countries.
Contamp Dial Nephrol 1995, 16 (3): 9 - 10
14. ARMENTA A, ABASTA M, FLORES R B
Coronary artery disease, associated with ESRD in Mexican
patients WCN 2007 Rio de Janeiro book of Abstracts s-po-115
15. ARORA P, OBRADOR GT, RUTHAZER R, KANS AT
Prevalence predictors and consequences of late nephrology
referral at tertiary casts and outcome Am J Kidney Dis 1998, 32(2): 278 -83
16. ASTOR BC, EUSTACE JA, POWE NR, et al
Timing of nephrologists referral and arterio veinous access use
: the choice study. Am J Kidney Dis 2000; 38(3):494-501
17. Australia and new Zeeland dialyses and transplant
registry. The twenty sixth report. Adelaide South Australia: ANZ DATA:
2003
18. AWAD RACHID, OMAR ABOUB, MOSTAFA TAHA, MOHAMED EL
SAYED Renal replacement therapy in Qatar
Saudi J Kidney Dis Transplant 1998, 9(1): 36-39
19. AZZABI A, FRIH A, GAHA K, GUEDRI Y ET AL
Evaluation de l'état nutritionnel des patients
hémodialysés au CHU Monastir 2ème congrès
maghrébin d'Alger, 2005.( livre des abstracts)
20. BARENSBROCK M, SPLEKER R, LASKE V, RALINAK H
Studies of the vassel wall properties in haemodialysis patients Kidney
Int 1994; 45:1397-1400
21. BARSOUM R S
End stage renal disease in the developpement word Arles organes
26: 735-736, 2000
22. BEHROOZ B, ALIZERA A, MOHAMED KAUFAR
Prevalence of infections and the risk factors in haemodialysis
in Teheran S J Kidney Dis Transplant 2002, 15(48):467-47
23. BENABADJI M.
Le traitement par hémodialyse itérative des
urémiques chroniques algériens : analyse et résultats
d'une enquête coopérative
Thèse de doctorat en sciences médicales : Alger :
1985
24. BENABADJI M., CHAMLA MC.
Les groupes sanguins ABO et Rh des algériens
L'anthropologie Masson Paris 1971, n°5-6, 427 - 442
25. BENHMIDA M. Current status of dialysis
therapy in the Arab country
S J Kidney dis transplant 2007: 17(5) 50-20
26. BERGUSTROM J, ALVESTRAND A, FRUST P
Plasma and muscle free amino-acids in maintenance haemodialysis
patients without protein malnutrition
Kidney Int 1990; 38: 108-14
27. BERTHOUX F, JONES E, GELLET R, MENDEL S, SAKER
L
Epidemiological dot of treated end stage renal tardive in
European union during the year 1995:report of the European association registry
and national registries
Nephrol Dial. Transplant 1999, 14:2332-42
28. BOUDRAY C
Insuffisance rénale chronique dans le Rhône
De la théorie à la pratique (thèse) Lyon :
université Claude Bernard : 1997
29. BOURQUIA A
La dialyse au Maroc : réalités et perspectives
Casablanca edits consultation 1996
Press; med 1997. 3(11): 126-6.
30. BRIAN D, BRADBURG M, RACHEL B, JUSTIN M
Predictors of early mortality among incidents US haemodialysis
patient in the dialysis outcomes and practice patterns study (dopps)
Clin J AM Soc Nephrol 2:89-99-2007
31. BRIGGS JD
The ERA-EDTA registry returns to Amsterdam Nephrol Dial
Transplant 2000, 15(9):1326-7
32. BUSH A, GABRIEL R
Pulmonary function in chronic renal failure: effect of dialyse
and transplantation thorax 1991, 46: 424-428
33. Bush P, Rasmussen S, Gialason GH et Al
Temporal declive in the prognostic impact of a recurrent acale
myocardial infraction 1985 to 2002, heart 2007, 93: 210-215
34. CECILE COUCHAUD, LUC FRIMAT, JEAN CLAUDE
ALDIGLER
Incidence et évaluation des traitements de
suppléance de l'IRCT dans sept régions françaises en 2003.
AMJ kidney 10 2005; 46:309-15
35. CENTER FOR DISEASES CONTROL
Department of Health and Human Services (1986)
Recommendation for providing treatment to patient infected with
human T lymphotopic virus type III, lymphoadenopathy associated virus
Ann Int Med 105-558
36. CENTRAL REGISTRY COMMITTEE, EREK E,
SERDENGEÇTI K. Registry of the nephrology dialysis and
transplantation in Turkey 2004
37. CHADNA SM, SCHULTZ J, LAURENCE C
Is the this a rational for ration rationing chronic dialysis. A
hospital based cohort study of factors affecting survival and morbidity
B. R Med J 1999, 318:217-23
38. CHAN MK,
Dialysis : a global perspective Dial. Transplant 1991;
20:463-7
39. CHARRAX B, CALEMARD E, RIFFE M, CHAZOTE C, TERRAT J
C, VANEL T et AL
Survival as an index of adequacy of dialysis
Kidney Int 1992; 41:1286-1296
40. CHAUVEAU P, CHADEFOUSE B, COUDE M, AUPETIT J,
HANNEDOUCHE T, KAMOUN P et AL
Hyperhomocysteinemia a risk factor arteriosclerosis in chronic
patients
Kidney int 1993; 43:572-597
41. CHAUVEAU P, COUDE M, AUPETIT J, HANNEDOUCHE T,
KAMOUN P et AL Hyperhomocysteinemia a risk factor for atherosclerosis
in chronic uraemia patients
Kidney Int 1993 ; 43 :572-577
42. CHENG AK
Quantitation of dialysis the importance of membrane and middle
molecules blood purify
1994; 42-53
43. CHURCHILL DN, TAYLOR DW, COOK RJ
Canadian haemodialysis morbidity study
Am J kidney dis 1992; 19: 214-234
44. Clase CM, Gray AX et al.
Prevalence of low glomerular filtration rate in no diabetic
Americans: third national health and nutrition examination survey
(NHANES III), J Am soc nephrology 2002, 13(5): 1338 - 49
.
45. COCKROFT DW, GAULT MH
Prediction of creatinine clearance from serum creatinine
Néphron 1976, 16(1): 31-41
46. CORESH J, BYRD-HOLT D, ASTOR BC, BRIGG
JP.
Chronic kidney disease awareness prevalence and trends among us
adults 1999 to 2000 J Am Soc Nephrol 2005; 16:180-8
47. COTTON JR, WOODAD J, CARTER NW, KNOCHEL JP
Resting skeletal muscle membrane potential as an index of uremic
toxicity J. Clin Invest 1999; 63:501 -506
48. COUCHAUD C, STENGEL B, JACQUELINE C.
Registre des traitements de suppléance de l'IRC. Rapport annuel
2002
Nephrol ther 2007, 3 (supp.1) : S1-S82 .rapport rein
49. COUCHAUD C, VILLAR E, FRIMAT L
Insuffisance rénale chronique terminale traitée
associée à un diabète : fréquence des conditions
d'initiation du traitement de suppléance en France en 2006
BEH 43 / 12 novembre 2008
50. DANESE et AL
Consistant control of mineral land bone disorder in incident
heamodialysis patients Clin J AM soc Nephrol 2008: 3(5) pp 1423-1429
51. DAKI S, ADDOU K, YAZIDI A, RAMDANI B ET
AL
Épidémiologie de l'IRCT : exemple des centres
d'hémodialyse publics du grand Casablanca. 2ème congrès
maghrébin de néphrologie d'Alger 2005
Livre des abstracts (posters) P75
52. DAVIS JW, FIELD MC, PHILLIPS PE, GRAHAM
B.
Effects of exogenous urea creatinemia and guanido no -succinic
acid on human platelet aggregation In Vitro - Blood 1972, 39:388-397
53. De Santos NG cappola S et Al. Predicted
creatinine clearance to assess glomerular filtration rate in chronic disease in
human.
Am J nephrol 2003, 11 (3): 181 - 5.
54. DENNIS V, ROBINSON K.
Homocysteinemia and vascular diseases in end stage renal
diseases Kidney Cut 1996, 50:511-517.
55. DRAZ-BUXO JA.
Automated peritoneal dialysis. A therapy in evolution in: Berlyne
GM, Ronco c eds Automated peritoneal dialysis. Contributions to nephrology.
Basel: Karger, 1999, 129: 1-14.
56. EBA A , Aghrabatt MS
Les complications cardiovasculaires chez l'insuffisant
rénal chronique terminal. Cardiologie tropicale ISSN 0253 - 580 2006,
volume 32 N°126, pp 19- 23
57. ELLIS PA, REDDY V, BARE N, CAIRNS HS Late
referral of end stage renal failure
QJM 1998, 91 (11):727-32.
58. ENY Imai et al
Prevalence of CKD in Japanese general population predicted by
the MDRD equation modified by Japanese coefficient
Clinical and experimental nephrology 2009: 11: 156-163
59. ELYOUBI , MAALOUF , BENZAKOUR
Hépatites virales chez les hémodialysés
dans la région de FES (Maroc) Revue d'épidémiologie et de
santé publique volume 57 N° 1 page 25 mai 2009
60. EUROPEAN RENAL ASSOCIATION EUROPEAN DIALYSIS AND
TRANSPLANTATION ASSOCIATION REGISTRY.
ERA-EDTA REGISTRY 2002: Annual report academic medical center
2004 Amsterdam 314.
61. FAISSAL AM, SHAHEEN S, ABDULLAH A, AKHADER,
Epidemiology and causes of ESRD
SJK Dis Transplant 2005, 16 (3):277-281
62. FASTBOM J, WILLS P, CORNEILIUS C ; VITANEM M,
WINBLAD B.
Levels of serum creatinine and estimated creatinine clearance
over the age of 75: a study of an elderly Swedish population
Arch Gerontol Geriatr 1996 ; 23 (2) :179-88
63. FEING HAN, LU YE, JLAGI QLAN ET AL
Social insurance cost of dialysis for patients with ESRD in
china WCN 2007 Rio de Janeiro Book of Abstracts s. p. o-455
64. FEUTON S, DESMENLES M, COPLESTEN P ET AL
Renal replacement therapy in Canadian: a report from the
Canadian organ replacement register. Am J Kidney Dis 1995, 25:134-50
65. FISSEL ET AL. Etude de la prévalence
et la séroconversion dans 7 pays (dopps)
Kidney int 65: 2335, 2004.
66. FOLEY ROBERT N. ,
Cardio-vascular disease survival in ESRD SKJ Dis Transpl 1999,
10 (4):455-463
67. FOLEY RN, PARFERY PS, HARNETT JD, KENT GM, MARLIN
CJ, MURRAY DC et Al Clinical and endocardiographic diseases in
patients starling and stage renal diseases therapy Kidney Int 1995 ; 47 :
186-192
68. FRANÇOISE MACRON NOGUES, MICHEL VERMAY, ERIC,
EKOUF ET AL.
La prévalence de l'insuffisance rénale chronique
terminale traitée par dialyse en France en 2003 : SROS-IRCT. AMJ Kidney
Dis 2005 (in press)
69. FREI U, SCHOBER H. J.
Renal replacement therapy in Germany. Annual report on dialysis
treatment and renal transplantation in Germany 2002-2003.
Quasi-niere g Gmbh 2003-Berlin
70. FRIMAT L.
Hémodialyse : les études
épidémiologiques. Les différences de résultats
conditionnées par l'état des patients, in : actualités
néphrologiques de l'hôpital de Necker. Paris:
Flammarion Medicine - sciences, 2003, p177.
71. FUJIYAMA S, KAWANO S
Sato setal changes in prevalence of anti-HCV antibodies
associated with preventive measures among haemodialysis patients and dialysis
staff.
Hepato-gastro-enterology 1995; 42 (2): 162-5
72. FULLADOZA X, GONZALEZ MT, CRUZARD JM
Metastatic pulmonary calcification in severe secondary
hyperparathyroidism Evaluation after renal transplantation.
Proc 1995, 27 : 2272-2276.
73. GAACHI A
Les aspects thérapeutiques des sténoses uretrales
Thèses DEMS: med: Allger: 2006
74. GHNAIMAT M, JUMAAN R, NIMRIM, EL LOZ M.
Acquired cystic diseases of kidney in chronic renal failure in
Jordany. Saudi J Kidney Dis Transplant 1998, (91): 4-7
75. GIONVAHNETTI S, LIONI L, BALESTRI PL, BRAGINI
M.
Evidence then guanidine and some related compound cause
haemodialysis in chronic uraemia. Clin Sci 1968, 34 : 141-148
76. GOERDT PJ, HUM - DUTHOY KL ET AL
Predictive performance of renal function estimate equation in
renal allograft. Br. J clin pharmacie 2001, 44(3) : 261 - 5.
77. GORANSSON LG, BERGREM H.
Consequences of referral of patients with ESRD. J. Intern Med
2001; 250 (2): 154-9
78. GAULT MH, LONGERISH L.L., HARNETT JD,
Predicty glomerular function from adjusted serum creatinine
Nephrol 2000, 62 (3): 249-56
79. HALIMI S, ZIMIRON D, BENHAMOU PY, BALDUCCI F, ZAOUI
P, MAGHLAOUA M et AL Huge progression of diabetes prevalence and
incidences among dialyzed patients in main land France and overseas French
Territories. A second national survey six years a part (UREMEDIAB 2 STUDY) Drob
Metab 1999, 25(6); 507-12
80. HALLAN SI, CORESH J, ASTOR BC, ASBERG A, ROUMINDSTAD
S ET AL.
International comparison of relationship of chronic kidney
disease prevalence and ERSD risk. J Am Soc Nephrol 2006, 17: 2275-84.
81. HALLAN SI
Screening strategy for CKD in the general population: follow up
of cross selectionnal survey BMJ 2008, 333; 1047-1052
82. HANNEDOUCHE T.
Epidémiologie et causes de l'IRC en France
Bulletin de l'académie nationale de médecine ISSN
0001-4079 coden 2008 volumes 188 N°8 pp 1455-1470
83. HANROTEL C, BINIDE P.
Prévention de l'hyperparathyroïdie II, l'IRC non
dialyses (étude physique), in : XXe symposium Gambro :
Néphrologie et santé publique Colombes.
1999-p169.
84. HARNETT JD, FOLLEY RN, KENT JM et AL.
Congestive heart failure in dialyses patients:
Prevalence, incidence prognosis and risk factors. Kidney Int
1995, 47:884-890.
85. HAUSER AM, HYM B, MICHOTEY O, GASCHT D, MARCHAL A,
MINERY M et AL Comparaison des méthodes de dosage de la
créatinine sérique.
Ann Biol Clin 2001; 59(6):737-42.
86. HEAF J, LOKKEQARD H, LARSEN S.
The epidemiology and prognosis of glomerulonephritis in Denmark
1985, 1997. Nephrol Dial. Transpl 1999; 14: 1889-97
87. HELD PJ, PORT FK, WOLFE RA, STANNARD D, CORROL CE,
DANGIRDAS JT et al The dose of haemodialysis and patients
mortality.
Kidney Int 1996; 50:550-556.
88. HSU CY, LIN F, wittinghof E,
Racial differences in the progressions from chronic renal
insuffisant to ESRD en USA JAM, soc nephrol 2003, 14: 2902 - 26
89. HUILI, CHUNPEN H, SHANPIAN HU et al
Projected budget reduction from increased utilisation of
peritoneal dialysis in China. WCN 2007 Rio de Janeiro Book of Abstracts s - po
- 452
90. HURARB SO.
Hepatitis C in dialysis patients SJKD 1995; 6:197-205
91. HUTTING J.
Predictive value of mitral and aortic valve stenosis for surview
in end stage renal disease on DPCA. Nephron 1993; 63-63-68.
92. IFUDU O, DAWOOD M, HOMEL P, FRIEDMAN EP
Excess morbidity in patients staring uraemia therapy without
prior car by nephrologists. AM J Kidney Dis 1996; 28(6):841-5
93. INNES A, ROWE PA, BURDEN RP, MORGAN AG.
Early death on renal replacement therapy: the need for early
morphological referral Nephrol Dial transplant 1992, 7(6): 467-71
94. INTERNATIONAL COMPARISON OF USRD THERAPY AM
J Kidney Dis 1997; 30(2) supp 1: S 187-S194
95. JACOBS C, SELWOOD NH.
Renal replacement therapy for ESNF in France: current statues
and devolutive trends over the last decade.
AM J K dis 1995;25:188-95
96. JADOUL ET AL.
European multicenter study HCV in haemodialysis Nephrol dial
transplant 2005.
97. JAMEL S, AL WAKEEL, AHMED MITWALLI
Morbidity and mortality in: ERSD patient on dialysis S. J kidney des
transplants 2003 (4); 73 - 777
98. JAMISON RC
Effets of homocysteine lowery or mortality and vascular disease
and ESRD : a randomiser control study
JAMA 2009 ; 298-1163-1170
99. JEAN CHRISTOPHE D, STEPHANIE GENTITE, BENEDIETE D,
BONGIOVANNI I, SAMBUC R. Caractéristiques epidemiologiques des
personnes âgées de 75 ans et plus.
Presse medicale 13. (12). 2003 tome 32. n°39
100. JELLIFE RW
Creatinine clearance: bedside astimate [letter] Ann intern
Nephrol 1997; 47 (4): 222-8
101. JONDEBY MS, SANTOS GG, AL GHAMADI A et AL
Caring for hemodialysis patients in Arabia: past present and future. S
Med Journal 2001, 22:199-204
102. JUNGERS P, CHAUVEAU P, DESCAMPES S, LATSHA B,
LABRUNIE M, GIRAND E, MAN NK et AL
Age and gender-related incidence of chronic renal failure in
french urban area: a prospective epidemiologic study.
Nephrol Dial Transplant 1996, 11(8): 1542-6
103. JUNGERS P, CHOUKROUN G, ROBINO C, MASSY ZA, TAUPIA
P et Al
Epidemiology of end stage renal disease in the Île de
France area: a prospective study in 1998 Nephrol Dial Transplant 2000,
15(12):2000-6
104. JUNGERS P, CHOUKROUN G, ROBINO C, TAUPIN P,
LABRUNIE M, MAN NK, LANDAIS Epidémiologie de l'IRCT en
île de France : enquête coopérative prospective en 1998.
Monographie vol 21. n°5 2000
105. JUNGERS P, MASSY ZA, NGUYEN-KHOA T, CHOUKROUN G,
ROBINO C, FAKHOURI F et AL.
Longer duration of predialysis nephrological care in associated
with improved long-term survival of dialysis patients.
Nephrol Dial. Transplant 2001, 16:2357-64
106. JUNGERS P, MAN NK, BABRUMIE M, TAUPIN P, et AL.
Incidence de l'IRCT en Ile de France : enquête epidemiologique
prospective. Press Med 2000 :589-92.
107. JUNGERS P, ROBINO C, CHOUKROUN G, FAKHOURI F,
GRUNFELD JP.
Evolution de l'épidémiologie de l'insuffisance
rénale et prévision des besoins de suppléances en
France.
Néphrologie 2001, 22(3) : 91-7.
108. JUNGERS P, SKHIRI H, ZINGRAFF J, MULLER S, FUMARON
C, GIATRAS I et AL. Bénéfices d'une prise en charge
néphrologiques précoce de l'IRC.
Press med 1997; 26(28): 1325-9
109. JUNGERS P, ZINGRAFF J, ALBONZE G, CHAUVEAU P, PAGE
B, HANNEDOUCHE T, et AL.
Late referral to maintenance dialysis: detrimental
consequences
Nephrol Dial Transplant 1993, 8(10): 1089-93
110. KAMOUN A, JUWAHDOU F, HACHICHA J ET AL
Cause of end stage chronic kidney failure in children in Tunisia Arch
Pediat is 4: 196 - 198. 1997
111. KAWAGISHI T, NISHIZAWA Y, KONISHI K, EMOTO
M.
High resolution B mode ultrasonography in evaluation of
atherosclerosis in uraemia Kidney Int 1995; 48: 820 - 826
112. KEISSER M. FRIMAT L. , PANESCU V. , BRIANÇON
S,
Impact of nephrology referral on early and mid-term outcomes in
ESRD: épidémiologie de l'IRCT en Lorraine (Epirel): resultats of
2 years prospective, community - based
AM J K Dis, 2003 p 478 - 8542.
113. KESSLER M ;
Insuffisance rénale chronique, étiologie,
physiopathologie diagnostic, principes du traitement Rev Prat 1998, 48(13):1457
- 63
114. KHAN IH, COTTO GR, EDWARD N, MAC LEAD AN
Chronic renal failure: factors influencing nephrology referral. QJM
1994. 87 (9): 559 - 64
115. KHAN IH, COTTO GR, EDWARD N, MAC LEAD AN
Death during the first 90 years of dialysis: a case control study. AM
J Kidney Dis 1995, 25 (2): 276 - 80
116. KIBERD BA, CLASE CM
Cumulative risk for developing ESRD in the us population JAM Soc
Nephrol 2002; 13:1635 - 44
117. KIM SK, GAFOR H, AHMAD G, MOHAMED R
Risk of sexual transmission of hepatitis C in haemodialysis
patients in Malaysia VCN 2007 Rio de Janeiro Book of Abstracts S - Po - 0193
118. KJELLSTRAND CM.
Duration and adequacy of dialysis over view The science is easy.
The ethic is difficult
AS A / OJ 1997; 43: 220 - 224
119. KROURI.
La dialyse péritonéale chronique ambulatoire dans
le traitement de l'insuffisance rénale chronique terminale
Thèse DESM. Med : Alger : 1985.
120. KUMKO A.W., RECORDAU P. Diabète
traité en France en 2007 :
Bulletin épidémiologique hebdomadaire, 12 novembre
2008 / n°43
121. LABBE D, VASSAULT A, CHERURAU B, BALTASSAT R,
BONNETTE R, COSTANTINI A ET AL
Validation et étude de la transferabilité de la
technique sélectionnée par la SFBC pour le dosage de la
créatinine dans le plasma.
Ann Biol. clin 1996 ; 56 (8-9) : 299-308.
122. LABEEUW M
Traitement de l'IRT par dialyse en Rhône Alpes :
évolution sur la période 1993 - 1999 Nephrologie 2001, 22 (4) :
161. 6
123. LAHAM GA, DIAZ C, SOLER PG,
Dialysis unit FME - CEMIC, renal section, cemic cinded de Buenos
Aires Argentine Comorbidités for the lade of benefit of an early start
of chronic dialysis
WCN 2007, Rio de Janeiro Book of abstracts S - po - 017
124. LAMERIE N, VAUVBIESSEN W,
The pattern of referral of patients with end stage renal disease
to the nephrologists : an European survey.
Nephrol Dial. Transplant 1999, 14 (supp 6) : 16-23
125. LANDON P.
Epidémiologie de la demande de soins
Presse Med 2002 ; 31 : 167 - 75 (USA + Japon)
126. LANDON P, STENGEL B, FUMERON C, JACQUELLINE
C
L'insuffisance rénale chronique terminale traitée
en France, épidémiologie et système d'information Med Ther
1998, 4:533-410
127. LARADI A.
Épidémiologie étiologie, clinique et
traitement de l'IRC évoluée en Algérie. Thèse de
doctorat en sciences médicales : Alger : 1982
128. LAVILLE M
Pour la pratique
Rev part 2001 ; 51(4) : 417-9
129. LEVEY AS ; BOSCH JP, LEWIS JB, GREENE T, ROGERS N ;
ROTH D,
A more accurate method to estimate glomerular filtration rate
from serum creatinine: a new prediction equation modification of diet in renal
disease study groupe
Ann Intern Med 1999; 130(6): 461 -70
130. LOCOTTELI F, MANZONI C,
Bio compatibility in haemodialysis fact and fiction Curr opin
Nephrol hyper tens 1997; 6: 528 - 32
131. LONDON GM, GUERIN AP, MARCHAIS SJ. Etat
cardiac and arterial interaction in end stage renal disease Kidney int 1996;
50: 600-608
132. LONDON GM, MARCHAIS SJ, GUERIN AP ET AL
Cardiovascular function in haemodialysis patients in: Grunfeld
JP, Bach JF, Franck Brenato eds. advances in nephrology Saint Louis Mosby
year's book, 1991, 249 - 273.
133. LOUNIS DOULKIFLY.
Hypertension artérielle chez le patient Diabétique
de type 2. THESE: DEMS med: Alger: 2005.
134. LUI W, HOOIL
Patients with ESRD: A registry al sultana Amina Hospital, Tohor
Bahru, Malaysia 2003 - 2004 WCN 2007 Rio de Janeiro Book of Abstracts s - po -
0558
135. LYSAGHIT M. ERSD incidence among community
mirrors that diab-besity and HN preventive.
J AM soc nephrol 2002.
136. MACRON-NOGUES F, VERNAY M, EKONG E, ET AL.
La prévalence de l'IRCT traitée par dialyse en France :
pratique et organisation des soins volume 38,
n°2 - Avril - Juin 2007.
137. MAISONNEUVE P, AGADA L, GELBERT R ET AL
Button of primary renal disease leading to ESR failure in the us
Europe and Australia / New Zeeland. Résultats from an international
comparative study.
Am J Kidney Dis 2000; 35: 157 - 65
138. MALLICK N, EL MARASI A, Chronic renal
failure
Cure int (3) 1999; 15 (3): 80 -4
139. MARLIN - REYES G, RAMOS B, FERNANDEZ GALLIO J
Factors relating to death in patient with ESRD failure on replacement
therapy WCN 2007 Rio de Janeiro Book of abstracts Ss - po - 0549.
140. MATSUBARA K, SULIMAN ME, QURESCHI RA
ESRD, dialysis - cardiovascular complications of ESRD including
outcomes, clinical trials. WCN 2007 Rio de Janeiro Book of abstracts S - po -
0364
141. MAY RC, MITCH WE
Physiopathology of uraemia Philadelphia:
WB Sanders, 1996:
chap 49: 2149 -2169
142. MC CURTHY JT,
A pratical approch to the management of patients with chronic
renal failure Mayo clin proc 1999, 74(3):269-73
143. MC DONALD SP, RUSS GR, KERR PG, COLLENS J.
F.
Australia and New Zeeland dialysis and transplant registry. ESRD
in Austria and New Zeeland at the end of Millennium: a report from the ANZ DATA
registry.
AM J Kidney Dis 2000, 40 (6): 1122 - 31
144. MEDKOUR G, AGHAI R, ANABI A, YAZID A, MOHAMED G,
BENGHANEM ET AL analysis of vascular access in haemodialysis patients
: A report from a dialysis unit in Casablanca. SJ Kidney Dis transplant
2006; 17(4): 51-520
145. MIGNON F, CATHERINE M. La dialyse
péritonéale ; le présent - l'avenir Le BDL vol 7 N° 4
pages 3
146. MITWALLI AH, AL SWAILEM AR, AZZIZ KOMS ET
AL
The incidence of end stage renal disease in two regions of
Kingdom of Saudi Arabia SJK Dis transplant 1995; 6(3): 280 -5
147. MOLDANADO MC, LANCHO ME, OVALLES V ET
AL
Venous catheter infections for haemodialysis at the Miguel Perez
careno hospital Caracas Venezuela WCN 2007 Rio de Janeiro Book abstract
148. MONTAGNAC R, SHILLINGER F, LAWAD S
Intérêt d'un registre des insuffisants rénaux
terminaux Expérience de la région Champagne-Ardenne
Néphrologie 2000; 21 (8) : 431 - 5
149. MOVILLI E, GAGGUA P, CAMERINI C ET AL
Association between high ultra filtration rates and mortality in
uremic patients on regular haemodialysis. A 5 years prospective observational
multicenter study (2000-2005)
WCN 2007 Rio de Janeiro Book of abstracts S - po - 0135
150. MUNNER A, AL NUSAIRAT I, KABIR MZ
Clinical profiles of chronic renal failure patients at referral
to nephrologists S J kidney Dis transp 2004, 15: 468 - 72
151. MUNOZ AS, DANUGUILAR RA, PADILA BS
The Philippine renal disease registry : demographic trends and
burden of illness ; 2001 - 2005 WCN 2007 Rio de Janeiro book of abstracts; s -
Po - 0550
152. NATIONAL KIDNEY FONDATION.
The kidney diseases outcomes quality initiatives (K/DOQI).
Clinical practice Guidelines for chronic diseases: evaluation,
classification, stratification AM J Kidney Dis 2002; 39 (2supp /1): S1 - 266
153. NORRIS KE, OWER W F J R.
The dilemma of hypertension in the African community Nephrology
news and issues 1995; 9(3): 14-16
154. NORRIS M, BENIGNI A, BOCCORDO P ; AILO S, GASPARI
F, TODESCHINI M ET AL Enchased nitric oxide synthesis in uraemia
implication for platelet dysfunction and dialysis hypotension Kidney Int 1993;
44: 445 -450
155. OGATA S, GILBERSTON DJ, CHEN S, FOLY NR
Regional affects on Japanese ESRD patients
WCN 2007 Rio de Janeiro book of abstracts S - po - 0542
156. PAREIRA BJG
La prévalence HVC.
Kidney Int 1997, 51: 981 - 99
157. PAREIRA BJG
Optimization of ESRD care: the key to improved dialysis outcome
Kidney Int 2000: 57: 351 - 65
158. PARFREY PS, FOLLEY RN, HARNETT JD ET AL
Outcomes and risk factors for left ventricular disorders in
chronic uraemia. Nephrol Dial Transplant 1996, 11, 1277 - 1285
159. PECORT - FILLOR R, BETTONI SL, VALENZUELA
V
The Brazilian multicentric study on peritoneal dialysis (ECMDP)
: characterisation of the cohort. WCN 2007 Rio de Janeiro book abstracts s - po
- 0232
160. PENECTO JMO, TAXEIRA R, CORAFFA WT
The seroprevalence of HCV in patients submitted to haemodialysis
and health professionals of Brazilian
WCN 2007 Rio de Janeiro Book of abstracts s - po - 0104
161. PERRONE RD, MADIAS NE ; LEVEY AS
Serum creatinine as an index of renal functions : New insights
into old conception Clin chem. 1992: 38 (10), 1933 -53
162. PIRAINO B.
Peritonitis as complications of peritoneal dialysis. J Am DOC
Nephrol 1998; 9: 1956 - 1962
163. POUTEIL - NOBLE C ; VILLAR E
Epidémiologie et étiologie de l'insuffisance
rénale chronique terminale Rev du Prat 2001 ; 51 (4) : 365 -71
164. PRICHARD SS
Morbidities and their impact on outcomes in patients with ESRD
Kidney int 2000: 57 (supp 74): 5100 - 5104
165. PRIORRY PA, HERITIER D. Traité des
altérations du sang
Paris JB Bailliere 1940
166. QUIMBI WY, A. SIABAR B, TAHER S, ALCHTAR M,
Renal disease in Saudi Arabia: study of 147 renal biopsies. King
Fayçal specialist hospital J. 1984; 4: 317-23
167. RAINES AE, MARGEITER R, BRUNNER FP. Report
on management of renal failure in Europe XXII, 1991 Nephrol Dial Transplant
1992; 7 (supp 2): 7-35
168. RAMPARASAD KS
Glomerulonephritis: lessons learnt from epidemiological studies
SJK Dis Transplant 2000, 11 (3): 291 - 294
169. RASHAD BARSOUM
Spectrum of glomerulonephritis in Egypt
Saudi J Kidney Transplant 2000; 11 (3): 42 - 429
170. RAYANE T, HADDOUM F
Chronic failure in Algeria, renal replacement therapy strategies
and progression (abstract) 1993 Saudi JK Dis transplant Bull 4(supp 1): 118
171. RAYANE
Insuffisance rénale chronique terminale, données
épidémiologiques Les cahiers de la santé N°17- 2002
page 16
172. REDDAN D, KLASSER P, FRANKENFULD DL ET
AL
National ESRD CPM work group national profile of practice
patterns for haemodialysis vascular access in United States
JAM Soc Nephrol 2002, 13 (8): 2117 - 24
173. Registry ERA-EDTA, ERA-EDTA
Registry 2004. Annual report. Academy medical canter, Amsterdam,
the Netherlands. July 2006 sites EDTA-ERA
174. REHLING M, MOLLER ML, THAMDRUP B ; TUND JO, TRAP -
JENSEN J.
Simultaneous measurement of renal clearance an plasma clearance
of 99 mTc - labelled diethylenetriaminepenta - acetate, 51 Cr - labelled
ethylenediamimeteta - acetate and inulin in man Clin Sci 1984 ; 66 (5) : 613
-9
175. REIN RAPPORT ANNUAL 2002.
Réseau épidémiologique et information en
néphrologie. Registre français des traitements de
suppléances de l'insuffisance rénale chronique.
Néphrol2003 ; 22 :91
176. REMUZZI G, PERICO N, ZOJA C, CERNA D
Role of endothelium derived nitric -oxide in oxid in the bleeding
tendences of uraemia. J Clin Invest 1990; 86: 1768 - 1771
177. RESIC H, MESIC E
Renal replacement therapy in Bosnia and Herzegovina 2002 - 2005
WCN 2007 Rio de Janeiro Book of abstracts s - po - 567
178. REZA A, SUZAM S, TAVAD S
Epidemiology of renal failure in Iran: four years single. Center
expérience SJK Dis Transplant 2007, 18 (2) : 191 - 194
179. RICORDEAN P, WEILL A, VALLIER N, BOURREL R ET AL
Epidémiologie du diabète en France
métropolitaine,
Diabètes metab 2000, 26 : 11 - 24
180. RITZ E, RAMBAUSSEK M, MALLE G ET AL
(1987)
Cardiac hypertrophy in uraemia. in chatelan C and Jacobs C ;
insuffisance rénale chronique Séminaire d'urologie -
Néphrologie (13 ème série)
Masson Paris 195 p
181. ROUBICEK C, BRUNET P, HWART L, THIMAU XET AL
Timing of nephrology referral: influence ou mortality and morbidility
An J Kidney sis 2003, 36(1) :35-41
182. ROWE JW, ANDRES R, TOBIN JD, NORRIS AH, SHOCK
NW.
The effect of age on creatinine clearance in men: a cross -
sectional and longitudinal study. J Gerontol 1976; 31 (2): 155 -63
183. SALMA MED SULIMAN; MOHAMED HASSEN BELLALA; HAROUN
HAMZA. Saudi J kidney and transplant 1995, (3), 312-314.
184. SANTACRUZ AC, JIMENEZ DJ, GUANUNA M :
Experience with 250 patients with catheter for haemodialysis WCN 2007,
Rio de Janeiro book of abstracts S-po- 0186.
185. SARAVANAU AK, JAYASEELAN TT, NANSY NL :
Prevalence of 25 (OH2) vit D deficiencies in chronic kidney
disease patient in tertiary care centre in INDIA.
WCN 2007 Rio de Janeiro. Book S-PO-0108.
186. SAVANI HN; NEPHROLOGY, SAVANI KIDNEY CARE CENTER,
SURAT, GUJARAT INDIA. Experience with etablissement of haemodialysis
center and programs in renal setting,
WCN 2007, Rio de Janeiro book of abstracts S-P-O 0116.
187. SCHMIDT JR, DOMICO JR SORKIN MI, HOBBS
G.
Early referral and his impact on emergent first dialyses, health
care costs, and outcome AM j kidney Dis 1998; 32(2); 278-83.
188. SCOT DATA 2003 SJK and Trans 2003; 13
(2):420-423
189. SCOT DATA, DIALYSIS IN THE KINGDOM OF SAUDI OF
ARABIA. SJK and Transplant 2001 ; 11(3) : 461-475.
190. SCOT DATA, DIALYSIS IN THE SKA. SJK Kidney
Dialysis transplant 2005, 16(3): 354-363.
191. SEBA A, BOULAHIA Y
Profil épidémiologique de la PKR dans la
région d'Alger 2ème congrès maghrébin de
néphrologie d'Alger
Livre des abstracts (communication orale)
192. SHAHEEN FA, AL KHADER AA : Epidemiology
and causes of ESRD
SJK and Dis transplant 2005, 16(13), 277:82.
193. SHAINKIN R, BIATT V, BERLYNE G
The toxicity of guando -compounds in the med blood cell in
uraemia and the effects of haemodialysis Nephron 1982, 37; 20-23.
194. SHALDON S
Adequacy of long terme haemodialysis
Curr Opin Nephrol hyper tens 1992; 1; 197-202.
195. SHARRU B, LAURENT G, GHAZOT C et AL :
Clinical Assessment of dry weight,
Nephrol Dial Transplant 1996; 11(supp2):9-16.
196. SHAW AB
Haemolyse in chronic renal failure B Med J 1967; 2: 213 - 216
197. SHEMESH O, GOLBETZ ET AL. Limitation of
creatinine as filtration marker in glomerulopathy patient.
Kidney int. 2005, 28 (5) : 830 - 8.
198. SHERBAN AK; abstract. Incidence of ESRD in
Yemen. EDTA -proceedings 1996 p 117
199. SHINZATO T, NAKAL S, AKIBA T, YAMAGAMI S ET AL
:
Report on the annual statistical survey of the Japanese society
for dialysis therapy in 1996; Kidney Int 1999, ss: 700-12.
200. SIM P ; BENARBIA S, CHARASSE C, STRAUSSCU C,
BELHAROUZ R ET AL : La nephroangiosclerose et la néphropathie
ischémique athéromateuse sont devenues les causes les plus
fréquentes de l'insuffisance rénale terminale chez les sujets
ages de plus de 60 ans Arch Mal Coeur Vais 1998, 91(8) ; 1065-8.
201. SIMON P, RAMEE M :
Intérêt de la biopsie rénale dans
l'étude epidemiologique des maladies rénales : La biopsie
Rénale : Paris INSREM ; 1996p 579-88.
202. SOLA L, SCHWEDT E, FORREIO A, MAZZUCHI N
:
Incidence of ESRD and association with sociodemographic factors
in a developing country, WCN 2007 Rio de Janeiro book of abstracts s-po-
547.
203. STEIN IVAR H, BJORN E.V.
Relation entre la prévalence de la néphropathie
glomérulaire et a risqué d'insuffisance rénale chronique
terminale.
Current opinion in vascular risk management, Vol / n°3 /
2008.
204. STEL VS, VAN DICK PCW, VAN MENEN JG :
Prevalence of comorbidity in different European RRT population
and its effect on access to renal transplantation.
Nephrol Dial Transp 2005(in press).
205. STENGEL B, BILLON S, VAN DIJK CW, TAGER KJ, DEKER
FW, SIMPSON K, BRIGGS D On behalf of the ERA-EDTA registry committee
trends in the incidence of renal replacement therapy for end stage renal
diseases en Europe 1990-1992
Nephrol Dial Transplant 2003; 18:1824-1833.
206. STOJCEVA-TAENEVA O, SELIM GGS :
Mortality in haemodialysis patients in the republic of
Macedonia: registry data 2002-2004. WCN 2007 Rio de Janeiro book of abstracts S
-PO- 0548.
207. STOVES J, BARTELLET CN. NEWSTEAD GG :
Specialist follows up of patients before end stage renal failure
and his relationship to survival on dialysis;
Post grad Med J 2001; 77(211): 586-8.
208. STYLIANO KG, PARAKIS K, MENIOUDAKIS G :
Comparison between surgical and percutaneous placement of
peritoneal dialysis catheter, a retrospective study.
WCN 2007 Rio de Janeiro book of abstracts S-PO- 0282.
209. SVOBODA L ; DRAGOMINECKA E : Quality of
life of CZECH dialysed patients. WCN 2007 Brazil book of abstracts S-P-O-
0130.
210. The renal association, united kingdom renal
registry. The sixth annual report Bristol, UK:
UK renal registry, December 2005.
211. THERESA N, IDRIZI A, STRAKOSHA A : ESDR
and renal replacement therapy in Albania
WCN 2007 Rio de Janeiro book of abstracts S-P-P -0193.
212. THOMPSON CH, KERN GJ, TAYLOR DJ et al :
Effect of chronic uraemia on skeletal muscle metabolism in man.
Nephrol Dial Transplant 1993; 8: 218- 222.
213. TOTO RD
Conventional measurement of renal function utilising serum
creatine, creatinine clearance, and Para amino hippuric acide clearance:
Curr Opin Nephrol Hyper tens 1995, 4 (6); 830-8.
214. TWARDAWSKI ZJ, NELP KD, KHANNA R :
Peritoneal equilibration test
Petit Dialyse Bult 1987, 7: 138-147.
215. United States renal data system. Usrds 2004
Annual data report, Bethesda, MD National institutes of health,
National institutes of diabetes and
digestives and kidney diseases 2007.
216. US RENAL DATA SYSTEM Annual data report
2003 Health people 2010
217. USRDS
Annual report 1998.
AMJ Kidney Dis, 2000; 63 (4) supp; 2- 124
218. USRDS :
The USRDS
AMJ Kidney Dis; 2003; 42 (6) supp 5 : 1 - 230
219. USRDS 1999
Annual data report
AMJ Kidney Dis 1999: 34 (supp 1) S1 - S 152
220. USRDS 1999
Annual data report national institute of health
National institutes of diabetes and digestive and Kidney
diseases. Bethesda, M, D, April 1999
221. USRDS 2004
Annual data report Atlas of ESRD. In the United States National
institutes of health, national institutes of diabetes and digestive and kidney
diseases
2004; Bethesda, MD
222. USRD ANNUAL DATA REPORT : BETHESDA MD
National institute of health and diabetes and digestive kidney disease
April 2002
223. US RENAL DATA SYSTEM.
USRDS 2006 Annual Data report: Atlas of ESRD in the United
States, national institutes of health. National Institutes of diabetes and
digestives and kidney diseases: Bethesda; MD, 2006 site URSD
224. US RENAL DATA SYSTEM 2007, ANNUAL DATA REPORT
Atlas of ESRD in the United States. National institutes of health.
Minneapolis USRDS, 2007.
225. US RENAL DATA SYSTEM 2008, ANNUAL DATA REPORT
Atlas of ESRD in the United States. National institutes of health.
Minneapolis USRDS, 2008.
226. VALDOVINOS R, VALDOVINOS M.
Echocardiography findings in haemodialysis patients,
departemento de nephrologia y cardiologia hospital nacional de Hangua Asuncion
Paraguay.
WCN 2007 Rio de Janeiro book of abstracts S-po-0114.
227. VALLENCE P, LEONE A, CALVER A, COLLER
J.
Accumulations of an endogenous inhibitor of nitric -oxid
synthesis in chronic renal failure. Lancet 1992; 1:572-575.
228. VAN DIJK P, TAGER KJ, DE CHARROF, COLLART F et
al.
Renal replacement therapy in Europe, the results of a
collaborative effort by the ERA-EDTA Registry and six national or regional
registries.
Nephrol Dial transplant 2001, 16:1120-9.
229. VAN DIJK PC, TAGER KJ, STENGEL B.
Cronhagen Risk feest TG, Briggs JD renal replacement therapy for
diabetic and stage renal diseases: data from 10registries in Europe 1991
2000
Kidney Int 2005; 65:1489-99.
230. VANHOLDER R.
Toxines uremiques in funk.
BRENTANO JL; BACH JF, KREIST H GRUNFELD JP EDS.
Actualités néphrologiques Jean Hamburger Paris:
Flammarion médecines sciences 1996:280-301.
231. VANHOLDER R, RINGEAR S.
Infections morbidity and deficits in phagocytic function in end
stage renal diseases A review JAM Soc Nephrol 1993; 3:1541-1554.
232. VANRENTERGHUM YF et AL Risk factor of
cardiovascular events after successful renal transplantation
Nephro Dial Transpl: 2008: 85209-216
233. VERGER C,
Comment utiliser le péritoine comme membrane de dialyse.
Nephrologie 1995, 16: 19- 3.
234. WALDERRABANO F, BERTHOU FC, JONES EH.
Report on management of renal failure in Europe; XXV 1994. ESRD
and dialysis report. the EDTAERA registry. European dialysis and transplant
association,
Nephrol Dial Trasplant 1996:11(supp) 2-21.
235. WALER DG, FLEMING JS, RAMSY B,
The accuracy of creatinine clearance with and without urine
collection as measure of glomerular filtration rate, post grad.
Med J 2000, 67 (783): 42-6.
236. WALSER MD.
Assessing renal function from creatinine measurement in adults
with chronic renal failure AMJ Kidney Dis 1998, 32(1):23-31.
237. WEINREISH T, MACITER R, RACH R.
Effeteness and safety of haemoglobin management with epoetin
beta, gain final results WCN 2007 Rio de Janeiro Book of Abstracts s -po
-450.
238. WIMMER F, OBERINGNER W, KRAMER R, MAYER
G.
Regional variability in the incidence of end stage renal
disease: an epidemiological approach Nephrol Dial Transplant 2003;
18:1562-7.
239. WITCH WE,
Dietary protein restriction in patients with chronic renal
failure Kidney Int 1991; 40:326-341.
240. WITCH WE.
Mécanisme de la perte de la masse musculaire chez
l'urémique in: Funk Brenatano JL, Beach JF, Kreis H, Grunfeld JP eds.
Actualités néphrologiques Jean Hamburger Paris
Flammarion médecines sciences 1996 :296r-278.
241. YEYATI NL, ANDROGENE HJ.
Inappropriately high plasma rennin activity accompanying chronic
of renal function. AMJ Nephrol 1996; 16:417-477.
242. YOUNG, MANGER EA, JIANG KH, PORT FK.
Socio economic statues and end stage renal diseases in United
States Kidney Int 1994, 45:97-11.
243. ZOCALI et AL
It is importance of homocystein in dialysis patient Semin dial
2009; 230: 530 - 533
| 
